Skip to main content

Elmind Capital, LP

SEC CIK
0002052213
Latest filing
Aug 14, 2026

VRDN holding history

Viridian Therapeutics, Inc. in every 13F filed by Elmind Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRDN overviewAll 13F holders of VRDNFull Q2 2026 holdings

Shares (Q2 2026)
984,931
Value
$18.1M
% of portfolio
4.5%
Quarters held
3
Since Q4 2025
Holdings of VRDN by Elmind Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026984,931$18.1M4.5%+450,000+84.1%AddedHolders
Q1 2026534,931$10.5M3.0%−323,700−37.7%ReducedHolders
Q4 2025858,631$26.7M7.9%–No prior filingHolders